STarT下肢筛查工具在下肢骨折患者中的信效度证据:一项前瞻性研究
该单中心前瞻性研究纳入114例无慢性疼痛史的下肢骨折患者,93%完成随访,评估改良版STarT下肢筛查工具(STarT-LE)的信效度。结果显示STarT-LE具有良好重测信度(ICC 0.85)和可接受内部一致性(α=0.74),聚合效度公平至中等(ρ 0.53-0.68),预测效度可接受至优秀(AUC 0.73-0.84),结论为该工具在下肢骨折患者中具有足够测量特性,但风险截断值需更大样本验证。
要点
- STarT-LE在下肢骨折患者中重测信度良好(ICC 0.85)且内部一致性可接受(α=0.74)。
- 聚合效度公平至中等(ρ 0.53-0.68,P<.001),预测效度可接受至优秀(AUC 0.73-0.84)。
- 风险截断值尚未验证,需未来更大规模研究确认。
核心结论
- STarT-LE在下肢骨折患者中具有足够的测量特性,可用于该人群。
- 未来需更大规模研究验证风险截断值。
研究设计与样本
- 单中心前瞻性研究,纳入114例无慢性疼痛史的下肢骨折患者,93%完成随访。
- 术后6周完成STarT-LE,部分样本1周后重测;6周和6个月完成参考问卷。
主要发现
- 重测信度ICC为0.85(95%CI 0.78-0.91),内部一致性Cronbach's α为0.74。
- 聚合效度Spearman ρ为0.53-0.68(P<.001),预测效度AUC为0.73-0.84。
关键数值与推荐
- 重测信度ICC 0.85(95%CI 0.78-0.91),内部一致性α=0.74。
- 聚合效度ρ 0.53-0.68(P<.001),预测效度AUC 0.73-0.84。
临床怎么用
- 可在下肢骨折术后6周使用STarT-LE评估患者心理社会风险分层。
- 当前风险截断值尚未验证,临床解读需谨慎。
局限性
- 单中心研究,样本量有限(N=114),风险截断值未验证。
- 需未来更大规模研究验证风险截断值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine whether a modified version of the STarT Back Screening Tool in its current structure has adequate properties for use in patients with lower extremity fracture. DESIGN: Single-center, prospective study. SETTING: Level I trauma center. PARTICIPANTS: Patients with lower extremity fracture without a history of chronic pain (N=114), with 93% follow-up. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Six weeks after surgical fixation, individuals completed the Subgroups for Targeted Treatment of Lower Extremity Screening Tool (STarT-LE). A subsample completed the STarT-LE again 1 week later. The following questionnaires were completed at 6 weeks and 6 months: Pain Catastrophizing Scale, Tampa Scale of Kinesiophobia, Brief Pain Inventory pain intensity subscale, and PROMIS Depression and Pain Interference computer adaptive testing modules. Reliability was evaluated using intraclass correlation coefficients (ICC) and Cronbach's alpha (α). Convergent validity evidence was measured concurrently using the Spearman ρ correlation between the 6-week STarT-LE and established questionnaires. Predictive validity evidence was evaluated by area under the curve analysis (AUC) using the 6-week STarT-LE total and psychosocial scores and 6-month criterion physical and psychosocial reference standards. RESULTS: The STarT-LE has good test-retest reliability (ICC, 0.85; 95% confidence interval, 0.78-0.91) and acceptable internal consistency (α=0.74). The convergent validity evidence was fair to moderate (ρ, 0.53-0.68; P<.001) and the predictive validity evidence was acceptable to excellent (AUC, 0.73-0.84). CONCLUSIONS: The STarT-LE has adequate properties for use in patients with lower extremity fracture. Future larger scale studies are needed to validate risk cutoffs.
引用
- Van Wyngaarden JJ, Noehren B, Pennings JS, et al. Reliability and Validity Evidence of the STarT-Lower Extremity Screening Tool for Patients With Lower Extremity Fracture: A Prospective Study. Arch Phys Med Rehabil. 2020. PMID: 33022272. doi:10.1016/j.apmr.2020.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。